“Biosecurity board grapples with how to rein in risky flu studies” (Science)
The National Science Advisory Board for Biosecurity met last week to discuss Gain of Function (GOF) studies. A topic of debate for the past several years, GOF studies involving H5N1 avian influenza and accidents at federal high containment laboratories caused the U.S. government to declare a moratorium in 2014. To find out more about the meeting, including the concerns and recommendations of opponents and researchers, read the article published in Science: http://www.sciencemag.org/news/2016/01/biosecurity-board-grapples-how-rein-risky-flu-studies
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.
Establishing an NIH Office of Infection-Associated Chronic Illness Research can guard against the long-term effects of Covid and lead to novel breakthroughs across many less understood diseases.